3 COVID Pill Stocks That Might Be Game-Changers
Despite the tremendous success of vaccines against the coronavirus, there's always more work to be done when it comes to reducing the risks associated with infection. And if the billions of dollars brought in by vaccine companies like Moderna didn't give it away, the market for coronavirus prevention and treatment is absolutely massive.
If coronavirus vaccine development was the story of 2020, antiviral pill development might well be the story of 2021 and 2022. Let's dive in and examine three of the most advanced pill makers to see what's going on, and when shareholders might see sales start to register.
Image source: Getty Images.
Source Fool.com
